Financials SMEDI Co., Ltd.

Equities

A118000

KR7118000009

Pharmaceuticals

End-of-day quote Korea S.E. 06:00:00 2024-04-29 pm EDT 5-day change 1st Jan Change
520 KRW +1.36% Intraday chart for SMEDI Co., Ltd. -0.57% +30.00%

Valuation

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Capitalization 1 52,115 88,756 143,380 122,388 44,045 57,110
Enterprise Value (EV) 1 46,163 82,977 153,583 93,005 49,346 38,063
P/E ratio -4.08 x -18.3 x 10.8 x 15 x -0.88 x -2.9 x
Yield - - - - - -
Capitalization / Revenue 1.51 x 1.58 x 5.33 x 6.58 x 2.31 x 1.02 x
EV / Revenue 1.34 x 1.48 x 5.71 x 5 x 2.58 x 0.68 x
EV / EBITDA -6.23 x -1,318 x -80.9 x -341 x 28.7 x -5.71 x
EV / FCF 10.8 x -20.7 x 7.48 x -5.09 x -2.07 x -7.38 x
FCF Yield 9.23% -4.83% 13.4% -19.6% -48.3% -13.6%
Price to Book 2.83 x 3.5 x 1.93 x 1.03 x 0.5 x 0.57 x
Nbr of stocks (in thousands) 24,296 24,896 50,397 81,321 84,703 142,775
Reference price 2 2,145 3,565 2,845 1,505 520.0 400.0
Announcement Date 3/19/19 3/17/20 3/17/21 3/21/22 3/22/23 3/20/24
1KRW in Million2KRW
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net sales 1 34,472 56,155 26,896 18,613 19,098 55,750
EBITDA 1 -7,413 -62.96 -1,899 -272.6 1,721 -6,669
EBIT 1 -8,105 -347.2 -2,156 -1,786 -240.5 -11,404
Operating Margin -23.51% -0.62% -8.01% -9.59% -1.26% -20.45%
Earnings before Tax (EBT) 1 -11,698 -3,854 12,310 7,497 -49,555 -26,174
Net income 1 -12,042 -4,803 11,252 7,740 -49,555 -14,540
Net margin -34.93% -8.55% 41.84% 41.58% -259.47% -26.08%
EPS 2 -526.0 -195.2 263.1 100.1 -591.0 -138.0
Free Cash Flow 1 4,261 -4,008 20,535 -18,274 -23,826 -5,158
FCF margin 12.36% -7.14% 76.35% -98.18% -124.76% -9.25%
FCF Conversion (EBITDA) - - - - - -
FCF Conversion (Net income) - - 182.49% - - -
Dividend per Share - - - - - -
Announcement Date 3/19/19 3/17/20 3/17/21 3/21/22 3/22/23 3/20/24
1KRW in Million2KRW
Estimates

Balance Sheet Analysis

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net Debt 1 - - 10,203 - 5,301 -
Net Cash position 1 5,951 5,779 - 29,383 - 19,047
Leverage (Debt/EBITDA) - - -5.374 x - 3.079 x -
Free Cash Flow 1 4,261 -4,008 20,535 -18,274 -23,826 -5,158
ROE (net income / shareholders' equity) -61.9% -14.9% 20.9% 10.1% -39.8% -19.5%
ROA (Net income/ Total Assets) -10.3% -0.33% -1.29% -0.71% -0.08% -4.13%
Assets 1 116,696 1,452,311 -869,117 -1,091,052 60,432,580 352,081
Book Value Per Share 2 757.0 1,020 1,477 1,468 1,040 703.0
Cash Flow per Share 2 1,449 519.0 292.0 728.0 336.0 141.0
Capex 1 119 61.7 91 26.5 109 535
Capex / Sales 0.34% 0.11% 0.34% 0.14% 0.57% 0.96%
Announcement Date 3/19/19 3/17/20 3/17/21 3/21/22 3/22/23 3/20/24
1KRW in Million2KRW
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

  1. Stock Market
  2. Equities
  3. A118000 Stock
  4. Financials SMEDI Co., Ltd.